Opinion|Videos|August 28, 2024

Optimizing ICI and TKI Combinations + Dose Reductions

Medical experts explore dose reduction strategies, alternative therapies, and clinical pearls for optimizing health outcomes in renal cell carcinoma patients treated with immune checkpoint inhibitor and tyrosine kinase inhibitor combinations.


Latest CME